Journal of general internal medicine
EBM BLS: Tirzepatide Remains Effective for Obesity Treatment and Diabetes Prevention at 3 Years of Follow-up.
John M Cunningham, Eric Nolan, Carlos Palacio
Published: 202510.1007/s11606-025-09988-4
No abstract available for this study.